Skip to main content
. 2019 Nov 28;47(3):713–720. doi: 10.1007/s00259-019-04584-1

Fig. 1.

Fig. 1

Kaplan-Meier plot shows median overall survival and median progression-free survival among the entire studied cohort. Patients received 3 cycles of highly standardized PSMA-RLT at 4 weekly intervals: The median overall survival was 119 weeks and the median progression-free survival was 25 weeks